Analysis of SNPs and Haplotypes in Vitamin D Pathway Genes and Renal Cancer Risk
Open Access
- 15 September 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (9) , e7013
Abstract
In the kidney vitamin D is converted to its active form. Since vitamin D exerts its activity through binding to the nuclear vitamin D receptor (VDR), most genetic studies have primarily focused on variation within this gene. Therefore, analysis of genetic variation in VDR and other vitamin D pathway genes may provide insight into the role of vitamin D in renal cell carcinoma (RCC) etiology. RCC cases (N = 777) and controls (N = 1,035) were genotyped to investigate the relationship between RCC risk and variation in eight target genes. Minimum-p-value permutation (Min-P) tests were used to identify genes associated with risk. A three single nucleotide polymorphism (SNP) sliding window was used to identify chromosomal regions with a False Discovery Rate of VDR (p-value = 0.02) and retinoid-X-receptor-alpha (RXRA) (p-value = 0.10) were associated with RCC risk. Within VDR, three haplotypes across two chromosomal regions of interest were identified. The first region, located within intron 2, contained two haplotypes that increased RCC risk by approximately 25%. The second region included a haplotype (rs2239179, rs12717991) across intron 4 that increased risk among participants with the TC (OR = 1.31, 95% CI = 1.09–1.57) haplotype compared to participants with the common haplotype, TT. Across RXRA, one haplotype located 3′ of the coding sequence (rs748964, rs3118523), increased RCC risk 35% among individuals with the variant haplotype compared to those with the most common haplotype. This study comprehensively evaluated genetic variation across eight vitamin D pathway genes in relation to RCC risk. We found increased risk associated with VDR and RXRA. Replication studies are warranted to confirm these findings.Keywords
This publication has 51 references indexed in Scilit:
- International Lung Cancer Consortium: Pooled Analysis of Sequence Variants in DNA Repair and Cell Cycle PathwaysCancer Epidemiology, Biomarkers & Prevention, 2008
- Vitamin D Receptor Polymorphisms and Renal Cancer Risk in Central and Eastern EuropeJournal of Toxicology and Environmental Health, Part A, 2008
- Resampling‐based multiple hypothesis testing procedures for genetic case‐control association studiesGenetic Epidemiology, 2006
- Association study of VDR gene with rheumatoid arthritis in the French populationGenes & Immunity, 2005
- Spatio-temporal Activation of Chromatin on the Human CYP24 Gene Promoter in the Presence of 1α,25-Dihydroxyvitamin D3Journal of Molecular Biology, 2005
- Cholecalciferol (Vitamin D3) Inhibits Growth and Invasion by Up-regulating Nuclear Receptors and 25-Hydroxylase (CYP27A1) in Human Prostate Cancer CellsClinical & Experimental Metastasis, 2005
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Novel Metabolism of 1α,25-Dihydroxyvitamin D3 with C24−C25 Bond Cleavage Catalyzed by Human CYP24A1Biochemistry, 2004
- Degradation of RXRs Influences Sensitivity of Rat Osteosarcoma Cells to the Antiproliferative Effects of CalcitriolMolecular Endocrinology, 2002
- Association of Vitamin D Receptor Gene Polymorphism with Renal Cell Carcinoma in Japanese.Endocrine Journal, 2002